SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-002746
Filing Date
2018-09-14
Accepted
2018-09-14 08:01:03
Documents
36
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR MARCH 31, 2018 cannapharmarx_10q-033118.htm 10-Q 182655
2 CERTIFICATION cannapharmarx_10q-ex3101.htm EX-31.1 8445
3 CERTIFICATION cannapharmarx_10q-ex3102.htm EX-31.2 7975
4 CERTIFICATION cannapharmarx_10q-ex32.htm EX-32 4323
  Complete submission text file 0001683168-18-002746.txt   966984

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cpmd-20180331.xml EX-101.INS 106153
6 XBRL SCHEMA FILE cpmd-20180331.xsd EX-101.SCH 12533
7 XBRL CALCULATION FILE cpmd-20180331_cal.xml EX-101.CAL 22365
8 XBRL DEFINITION FILE cpmd-20180331_def.xml EX-101.DEF 14469
9 XBRL LABEL FILE cpmd-20180331_lab.xml EX-101.LAB 87657
10 XBRL PRESENTATION FILE cpmd-20180331_pre.xml EX-101.PRE 66957
Mailing Address 2 PARK PLAZA, STE. 1200-B IRVINE CA 92614
Business Address 2 PARK PLAZA, STE. 1200-B IRVINE CA 92614 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 181070110
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1